Louis G Lange
Director · 2 filings · Latest: Mar 11, 2026
NewAmsterdam Pharma Co N.V.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NAMS | Louis G Lange | Director | Mar 11, 2026 | Sale | $30.42 | 44,619 | $1.4M | 10,360 | |
NAMS | Louis G. Lange | — | Mar 11, 2026 | Proposed Sale | $31.27 | 44,619 | $1.4M | — | |
NAMS | Louis G Lange | Director | Mar 6, 2026 | Sale | $29.41 | 28,186 | $829.0K | 0 | |
NAMS | Louis G. Lange | — | Mar 6, 2026 | Proposed Sale | $31.18 | 28,186 | $878.8K | — |